Fed Circ finds another CardioNet patent-ineligible under Alice

The US Court of Appeals for the Federal Circuit has ruled that yet another CardioNet heart monitor patent is invalid for not citing an inventive concept under the Alice test.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

InfoBionic wants fees of $2.9m in ‘exceptional’ CardioNet suit

23 December 2021 Medical devices company InfoBionic has argued that it should be awarded nearly $2.9 million in fees for attorneys, expenses and expert witnesses.

Americas

Number of patents invalidated by Alice drops by 23%

11 July 2019 There has been a significant drop in the number of patents invalidated due to so-called Alice challenges since Federal Circuit rulings in Berkheimer v HP, and Aatrix Software v Green Shades Software, according to a new report.

Americas

Fed Circuit backs Endo in Alice suit over oxymorphone patent

29 March 2019 The US Court of Appeals for the Federal Circuit yesterday, March 28, overturned a district court decision and handed a victory to pharmaceutical companies Endo and Mallinckrodt.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Fed Circ finds another CardioNet patent-ineligible under Alice

More on this story

Editor's picks

Editor's picks

More features